Cervical cancer immunotherapy: facts and hopes
It is a sad fact that despite being almost completely preventable through human
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …
papillomavirus (HPV) vaccination and screening, cervical cancer remains the fourth most …
The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
C Patel, JML Brotherton, A Pillsbury… - …, 2018 - eurosurveillance.org
Background: A National human papilloma virus (HPV) Vaccination Programme for the
prevention of HPV infection and associated disease using the quadrivalent HPV vaccine …
prevention of HPV infection and associated disease using the quadrivalent HPV vaccine …
Perspectives for therapeutic HPV vaccine development
Background Human papillomavirus (HPV) infections and associated diseases remain a
serious burden worldwide. It is now clear that HPV serves as the etiological factor and …
serious burden worldwide. It is now clear that HPV serves as the etiological factor and …
Hallmarks of HPV carcinogenesis: The role of E6, E7 and E5 oncoproteins in cellular malignancy
D Estêvão, NR Costa, RMG da Costa… - Biochimica et Biophysica …, 2019 - Elsevier
Human papillomavirus (HPV) is the most common sexually transmitted infectious agent
worldwide, being also responsible for 5% of all human cancers. The integration and …
worldwide, being also responsible for 5% of all human cancers. The integration and …
Immunotherapy in ovarian, endometrial and cervical cancer: state of the art and future perspectives
J Ventriglia, I Paciolla, C Pisano, SC Cecere… - Cancer treatment …, 2017 - Elsevier
The tumors of the female genital tract represent a leading cause of morbidity and mortality
among women worldwide. Substantial progresses have been made in ovarian cancer, with …
among women worldwide. Substantial progresses have been made in ovarian cancer, with …
[PDF][PDF] Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
Cervical cancer is the fourth most lethal women's cancer worldwide. Current treatments
against cervical cancer include surgery, radiotherapy, chemotherapy, and anti-angiogenic …
against cervical cancer include surgery, radiotherapy, chemotherapy, and anti-angiogenic …
The human papillomavirus E6 PDZ binding motif: from life cycle to malignancy
Cancer-causing HPV E6 oncoproteins are characterized by the presence of a PDZ binding
motif (PBM) at their extreme carboxy terminus. It was long thought that this region of E6 had …
motif (PBM) at their extreme carboxy terminus. It was long thought that this region of E6 had …
Current state in the development of candidate therapeutic HPV vaccines
A Yang, J Jeang, K Cheng, T Cheng… - Expert review of …, 2016 - Taylor & Francis
The identification of human papillomavirus (HPV) as an etiological factor for HPV-associated
malignancies creates the opportunity to control these cancers through vaccination …
malignancies creates the opportunity to control these cancers through vaccination …
British HIV Association guidelines on the use of vaccines in HIV-positive adults 2015
AM Geretti, G Brook, C Cameron, D Chadwick… - HIV …, 2016 - discovery.ucl.ac.uk
These guidelines provide updated, GRADE-based recommendations on the use of vaccines
in HIVpositive adults. Several factors have made the updating of HIV-specific vaccination …
in HIVpositive adults. Several factors have made the updating of HIV-specific vaccination …
Special issue about head and neck cancers: HPV positive cancers
P Economopoulou, I Kotsantis, A Psyrri - International journal of molecular …, 2020 - mdpi.com
The oropharynx has become the leading primary site for Human Papilloma Virus (HPV)-
associated head and neck cancer. HPV positive oropharyngeal squamous cell carcinoma …
associated head and neck cancer. HPV positive oropharyngeal squamous cell carcinoma …